Helen S. Kim's most recent trade in Prothena Corporation plc was a trade of 20,183 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prothena Corporation plc | Helen S. Kim | Director | 14 May 2025 | 20,183 | 20,183 | - | - | Stock Option (Right to Buy) | ||
| Prothena Corporation plc | Helen S. Kim | Director | 15 May 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Prothena Corporation plc | Helen S. Kim | Director | 17 May 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Applied Molecular Transpor... | Helen S. Kim | Director | Sale of securities on an exchange or to another person at price $ 30.08 per share. | 24 Aug 2021 | 9,478 | 590,014 | - | 30.1 | 285,075 | Common Stock |
| Applied Molecular Transpor... | Helen S. Kim | Director | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 24 Aug 2021 | 505 | 599,495 | - | 30.0 | 15,165 | Common Stock |
| Applied Molecular Transpor... | Helen S. Kim | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 24 Aug 2021 | 3 | 599,492 | - | 30 | 90 | Common Stock |